Advertisement

Cardiovascular Disease Risk Factors in Chronic Kidney Disease in Children

  • Mark M. Mitsnefes
    Correspondence
    Address reprint requests to Mark M. Mitsnefes, MD, MS, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, MLC: 7022, 3333 Burnet Ave, Cincinnati, OH 45229-3039.
    Affiliations
    Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
    Search for articles by this author
      Summary: Over the past 2 decades, cardiovascular (CV) disease has been recognized as one of the most important complications of chronic kidney disease (CKD) and one of the leading causes of death in children with advanced CKD and in young adults who developed CKD during childhood. CV abnormalities develop early and progress during the course of CKD in children. Characterization of the prevalence and evolution of CV disease risk factors in progressive CKD is one of the primary aims of the Chronic Kidney Disease in Children study. In this review, we summarize up-to-date findings from the Chronic Kidney Disease in Children study with a focus on traditional and CKD-related CV risk factors and early subclinical markers of cardiac and vascular structure and function. We also discuss the effect of CV risk factors on progression of CKD.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Nephrology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Flynn JT
        • Mitsnefes M
        • Pierce C
        • et al.
        Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study.
        Hypertension. 2008; 52: 631-637
        • Samuels J
        • Ng D
        • Flynn JT
        • et al.
        Ambulatory blood pressure patterns in children with chronic kidney disease.
        Hypertension. 2012; 60: 43-50
        • Kogon AJ
        • Pierce CB
        • Cox C
        • et al.
        Nephrotic-range proteinuria is strongly associated with poor blood pressure control in pediatric chronic kidney disease.
        Kidney Int. 2014; 85: 938-944
        • Barletta G
        • Pierce C
        • MItsnefes M
        • Samuels J
        • Warady B
        • Furth S
        • et al.
        Are blood pressure indices improving in children with chronic kidney disease? A period analysis.
        Hypertension. 2018; 71: 444-450
        • Reynolds BC
        • Roem JL
        • Ng DKS
        • et al.
        Association of time-varying blood pressure with chronic kidney disease progression in children.
        JAMA Netw Open. 2020; 3e1921213
        • Warady BA
        • Abraham AG
        • Schwartz GJ
        • et al.
        Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: The Chronic Kidney Disease in Children (CKiD) cohort.
        Am J Kidney Dis. 2015; 65: 878-888
        • Ku E
        • McCulloch CE
        • Warady BA
        • Furth SL
        • Grimes BA
        • Mitsnefes MM
        Twenty-four-hour ambulatory blood pressure versus clinic blood pressure measurements and risk of adverse outcomes in children with CKD.
        Clin J Am Soc Nephrol. 2018; 13: 422-428
        • Saland JM
        • Pierce CB
        • Mitsnefes MM
        • et al.
        Dyslipidemia in children with chronic kidney disease.
        Kidney Int. 2010; 78: 1154-1163
        • Saland JM
        • Kupferman JC
        • Pierce CB
        • et al.
        Change in dyslipidemia with declining glomerular filtration rate and increasing proteinuria in children with CKD.
        Clin J Am Soc Nephrol. 2019; 14: 1711-1718
        • Wilson AC
        • Schneider MF
        • Cox C
        • et al.
        Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease.
        Clin J Am Soc Nephrol. 2011; 6: 2759-2765
        • Lalan S
        • Jiang S
        • Ng DK
        • et al.
        Cardiometabolic risk factors, metabolic syndrome, and chronic kidney disease progression in children.
        J Pediatr. 2018; 202: 163-170
        • Mitsnefes M
        • Flynn J
        • Cohn S
        • et al.
        Masked hypertension associates with left ventricular hypertrophy in children with CKD.
        J Am Soc Nephrol. 2010; 21: 137-144
        • Kupferman JC
        • Aronson Friedman L
        • Cox C
        • et al.
        BP control and left ventricular hypertrophy regression in children with CKD.
        J Am Soc Nephrol. 2014; 25: 167-174
        • Hanevold C
        • Waller J
        • Daniels S
        • Portman R
        • Sorof J
        • International Pediatric Hypertension Association
        The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association.
        Pediatrics. 2004; 113: 328-333
        • Brady TM
        • Roem J
        • Cox C
        • et al.
        Adiposity, sex, and cardiovascular disease risk in children with CKD: a longitudinal study of youth enrolled in the Chronic Kidney Disease in Children (CKiD) study.
        Am J Kidney Dis. 2020; 76: 166-173
        • Gutierrez OM
        • Mannstadt M
        • Isakova T
        • et al.
        Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
        N Engl J Med. 2008; 359: 584-592
        • Isakova T
        • Xie H
        • Yang W
        • et al.
        Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
        JAMA. 2011; 305: 2432-2439
        • Scialla JJ
        • Xie H
        • Rahman M
        • et al.
        Fibroblast growth factor-23 and cardiovascular events in CKD.
        J Am Soc Nephrol. 2014; 25: 349-360
        • Gutierrez OM
        • Januzzi JL
        • Isakova T
        • et al.
        Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
        Circulation. 2009; 119: 2545-2552
        • Faul C
        • Amaral AP
        • Oskouei B
        • et al.
        FGF23 induces left ventricular hypertrophy.
        J Clin Invest. 2011; 121: 4393-4408
        • Mitsnefes MM
        • Betoko A
        • Schneider MF
        • et al.
        FGF23 and left ventricular hypertrophy in children with CKD.
        Clin J Am Soc Nephrol. 2018; 13: 45-52
        • Brady TM
        • Townsend K
        • Schneider MF
        • et al.
        Cystatin C and cardiac measures in children and adolescents with CKD.
        Am J Kidney Dis. 2017; 69: 247-256
        • Patel PC
        • Ayers CR
        • Murphy SA
        • et al.
        Association of cystatin C with left ventricular structure and function: the Dallas Heart Study.
        Circ Heart Fail. 2009; 2: 98-104
        • Angelidis C
        • Deftereos S
        • Giannopoulos G
        • et al.
        Cystatin C: an emerging biomarker in cardiovascular disease.
        Curr Top Med Chem. 2013; 13: 164-179
        • Sam F
        • Siwik DA
        Digesting the remodeled heart: role of lysosomal cysteine proteases in heart failure.
        Hypertension. 2006; 48: 830-831
        • Koenig W
        • Twardella D
        • Brenner H
        • Rothenbacher D
        Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.
        Clin Chem. 2005; 51: 321-327
        • Toth PP
        Subclinical atherosclerosis: what it is, what it means and what we can do about it.
        Int J Clin Pract. 2008; 62: 1246-1254
        • Lorenz MW
        • Markus HS
        • Bots ML
        • Rosvall M
        • Sitzer M
        Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis.
        Circulation. 2007; 115: 459-467
        • Brady TM
        • Schneider MF
        • Flynn JT
        • et al.
        Carotid intima-media thickness in children with CKD: results from the CKiD study.
        Clin J Am Soc Nephrol. 2012; 7: 1930-1937
        • Madueme PC
        • Ng DK
        • Guju L
        • et al.
        Aortic dilatation in children with mild to moderate chronic kidney disease.
        Pediatr Nephrol. 2020; 35: 1023-1031
        • Kaddourah A
        • Uthup S
        • Madueme P
        • et al.
        Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal disease.
        Clin Nephrol. 2015; 83: 262-271
        • Gupta-Malhotra M
        • Devereux RB
        • Dave A
        • Bell C
        • Portman R
        • Milewicz D
        Aortic dilatation in children with systemic hypertension.
        J Am Soc Hypertens. 2014; 8: 239-245
        • Oliveira EA
        • Zheng R
        • Carter CE
        • Mak RH
        Cachexia/protein energy wasting syndrome in CKD: causation and treatment.
        Semin Dial. 2019; 32: 493-499